Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:9/13/2018
Start Date:December 2014
End Date:November 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
To assess positive blood cultures (PBCs) in hemodialysis central venous catheter (CVC)
patients using two FDA cleared devices: ClearGuard HD end caps compared to conventional end
caps.


Inclusion Criteria:

- All patients dialyzing with a central venous catheter

Exclusion Criteria:

- Known allergy to chlorhexidine
We found this trial at
1
site
Frenova Renal Research
Waltham, Massachusetts 02541
?
mi
from
Waltham, MA
Click here to add this to my saved trials